Creating the future in peptides

We lead innovation in peptide API’s to the benefit of millions of patients

Contact us

Market leader in peptide API manufacturing and services

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API). 

Expert views

PolyPetide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

27 Nov 2025 - Presented at TIDES Europe, 12 November 2025 Speaker: Francesco Terzani, Scientist Innovation Abstract: The global rise in peptide demand, driven by accelerated clinical development and speed to […]

Read more
Business news

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

28 Oct 2025 - Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract […]

Read more

PolyPeptide video

PolyPeptide Group - Ahead on green peptide chemistry